FdaApplication
ANDA 212629
Identifiers
- fda_app_no: ANDA212629
Properties
| Property | Value |
|---|---|
| applicant_name | POINTVIEW HOLDINGS LLC |
| application_type | ANDA |
| approval_date | 2023-12-05 |
Products (3)
| Product | Active ingredient | Strength | Dosage form |
|---|---|---|---|
| PREDNISONE | PREDNISONE | 10MG | TABLET;ORAL |
| PREDNISONE | PREDNISONE | 20MG | TABLET;ORAL |
| PREDNISONE | PREDNISONE | 5MG | TABLET;ORAL |
3 products